Tilray Receives First New Cannabis Cultivation License in Germany Under New Regulations New cannabis cultivation license allows Aphria RX to cultivate a range of higher quality medical cannabis produced in Germany.

Tilray Medical Announces Scientific Study on Medical Cannabis for Patients Over Age 50 Tilray-led scientific publication examines the real-world impact of medical cannabis use on patients over the age of 50.

Tilray Medical Applauds German Bundestag and Landmark Passage of Medical Cannabis Act in Germany Tilray Medical welcomes the opening of the German medical cannabis market and the positive paradigm shift in German drug policy.